Joseph H Phillips

This inventor holds 24 USPTO granted patents and 14 published patent applications and 4 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Schering Corporation, Becton Dickinson and Company Limited, Merck Sharp + Dohme Corp.. Active years: 1986-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph H Phillips. Retrieved from https://idiyas.com/inventor/joseph-h-phillips

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 14)

% Patents Active = 58.3

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 663(Granted Patents)

Location History:

Redwood City, CA (US) (1986)
San Mateo, CA (US) (1990 - 1991)
San Carlos, CA (US) (1992 - 1999)
Houston, TX (US) (2003 - 2005)
San Francisco, CA (US) (2012)
Palo Alto, CA (US) (2000 - 2017)

Company Filing History:

Becton Dickinson and Company Limited

patents

2 out of 2,405

Merck Sharp + Dohme Corp.

patents

4. 1 out of 5,512

Leland Stanford Junior University

patents

5. 3 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2017

Loading Chart...

Areas of Expertise:

PD-1 Antagonist

Bispecific Antibodies

CD200 Receptors

Tumor Growth Inhibition

NK Cells

Immunotherapy

Antibodies

FDF03 Antibodies

DAP12 Proteins

MDL-1 Ligand

Cytotoxic T Lymphocytes

Cell Subpopulation Monitoring

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9827309 - Treating cancer with a combination of a PD-1 antagonist and dinaciclib (2017-11-28),

2. 9284377 - MDL-1 ligand (2016-03-15),

3. 8263070 - Methods of modulating CD200 receptors (2012-09-11),

4. 8236309 - Use of bispecific antibodies to regulate immune responses (2012-08-07),

5. 8212008 - Antibodies to CD200R (2012-07-03),

6. 8178094 - Methods for inhibiting tumor growth or reducing metastatic burden in a subject by administering FDF03 antibodies (2012-05-15),

7. 8153134 - Anti-MDL-1 antibodies (2012-04-10),

8. 7999078 - Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptor (2011-08-16),

9. 7659093 - DAP12 nucleic acids (2010-02-09),

10. 7332574 - MDL-1 polypeptides (2008-02-19),

11. 7319140 - Binding compounds to DAP12 proteins (2008-01-15),

12. 6953843 - Antibodies and fragments thereof to MDL-1 protein (2005-10-11),

13. 6873261 - Early warning near-real-time security system (2005-03-29),

14. 6559769 - Early warning real-time security system (2003-05-06),

15. 6479638 - Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor (2002-11-12),

Title: The Inventor Joseph H Phillips: Pioneering Innovations in Palo Alto

Introduction: Joseph H Phillips is a renowned inventor based in Palo Alto, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Joseph H Phillips holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Joseph H Phillips has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Joseph H Phillips has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to numerous successful projects and products.

Conclusion: Joseph H Phillips continues to be a driving force in the world of technology and innovation, with his passion for pushing boundaries and creating solutions that make a difference.

Profile summary based on public USPTO records.